GSK: ‘Armageddon’ Claims Overstated For Skinny-Label Generics
Originator Pushes Back Against Teva Petition For Federal Circuit ‘En Banc’ Rehearing
• By David Wallace
GSK insists the decisions do not represent “doomsday” for skinny labels • Source: Alamy 
